nnpNeurology, Neuropsychiatry, PsychosomaticsНеврология, нейропсихиатрия, психосоматика2074-27112310-1342"IMA-Press", LLC10.14412/2074-2711-2011-161nnp-313Research ArticleCLINICAL OBSERVATIONSКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯEpilepsy and nicotine: Clinical observations and a review of literatureЭпилепсия и никотин: клинические наблюдения и обзор литературыЗенковЛ. Р.ZenkovL. R.
лабратория клинической нейрофизиологии
zenkov@mmascience.ruШатенштейнА. А.ShatenshteinA. A.info@ima-press.netКлиника нервных болезней им. А.Я. КожевниковаRussian FederationКлиника психиатрии им. С.С. Корсакова Первого МГМУ им. И.М. СеченоваRussian Federation20111309201133NO3 (2011)1823Copyright © Zenkov L.R., Shatenshtein A.A., 20112011Зенков Л.Р., Шатенштейн А.А.Zenkov L.R., Shatenshtein A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://nnp.ima-press.net/nnp/article/view/313
.
References<div><p>Статистика курения. russlav.ru _ stat/statis-tika_kyreniya.html</p><p>IARC. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.</p><p>WHO. http://www.who.int/mediacentre/news/releas- es/pr82/en. 2002</p><p>WHO. http://www.who.int/tobacco/health_priority/en /print.html. 2007.</p><p>Dworetzky B.A., Bromfield E.B., Townsend M.K. et al. A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: data from the Nurses' Health Study II. Epilepsia 2010;51:198-205.</p><p>Elliott J.O., Lu B., Moore J.L. et al. Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on the California Health Interview Survey, 2005. Epilepsy Behav 2008;13:307-15.</p><p>Elliott J.O., Moore J.L., Lu B. Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System. Epilepsy Behav 2008;12:434-44.</p><p>Kobau R., DiIorio C.A., Price P.H. et al. Prevalence of epilepsy and health status of adults with epilepsy in Georgia and Tennessee: Behavioral Risk Factor Surveillance System, 2002. Epilepsy Behav 2004;5:358-66.</p><p>Konda K., Ablah E., Konda K.S. et al. Health behaviors and conditions of persons with epilepsy: a bivariate analysis of 2006 BRFSS data. Epilepsy Behav 2009;16:120-7.</p><p>Зенков Л.Р. Клиническая эпилептология (руководство для врачей). 2-е изд. М.: МИА, 2010;408 с.</p><p>Usui N., Kotagal P., Matsumoto R. et al. Focal semiologic and electroencephalographic features in patients with juvenile myoclonic epilepsy. Epilepsia 2005;46:1668-76.</p><p>Panayiotopoulos C.P. A clinical guide to epileptic syndromes and their treatment. Springer, 2010;620 р</p><p>Reinsberger C., Dorn T., Kramer.G. Smoking reduces serum levels of lamotrigine. Seizure 2008;17:651-3.</p><p>Hong E.L., Gu H., Yang Y. et al. Association of Nicotine Addiction and 14. Nicotine's Actions With Separate Cingulate Cortex Functional Circuits. Arch Gen Psychiat 2009;66:431-41.</p><p>Albuquerque E.X., Pereira E.F.R., Alkondon M. et al. Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function. Physiol Rev 2009;89:73-120.</p><p>Court J.A., Piggott M.A., Lloyd S. et al. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 2000;98:79-87.</p><p>Orth M., Amann B., Robertson M.M. et al. Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. Brain 2005;128:1292-300.</p><p>Silver A.A., Shytle R.D., Philipp M.K. et al. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. J Clin Psychiatry 2001;62:707-14.</p><p>White H.K., Levin E.D. Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. Psychopharmacology 2004;171:465-71.</p><p>Berkovic S.F., Scheffer I.E. Genetic of partial epilepsies: new frontiers. In: Genetics of focal epilepsies: Berkovic S.F., Genton P., Picard F. (eds.) Clinical aspects and molecular biology. John Libbey & Company Ltd., 2000;7-14.</p><p>Chen Y., Wu L., Fang Y. et al. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. Epilepsy Res 2009;83:152-6.</p><p>Fedi M., Berkovic S.F., Scheffer I.E. et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy. Neurology 2008;71:795-8</p><p>Hoda J.C., Gu W., Marc F. et al. Human Nocturnal Frontal Lobe Epilepsy: Pharmocogenomic Profiles of Pathogenic Nicotinic Acetylcholine Receptor β-Subunit Mutations outside the Ion Channel Pore. Mol Pharmacol 2008;74:379-91.</p><p>Kedmi M., Orr-Urtreger A. Expression changes in mouse brains following nicotine-induced seizures: the modulation of transcription factor networks. Physiol Genomics 2007;30:242-52.</p><p>Mulley J.C., Scheffer I.E., Petrou S. et al. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003;16:171-6.</p><p>Phillips H.A., Favre I., Kirkpatrick M. et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001;68:225-31.</p><p>Steinlein O.K. Human disorders caused by the disruption of the regulation of excitatory neurotransmission. Results Probl Cell Differ 2008;44:223-42.</p><p>Willoughby J.O., Pope K.J., Eaton V. Nicotine as an antiepileptic agent in ADNFLE: an N-of-one study. Epilepsia 2003;44:1238-40.</p><p>Lloyd G.K., Menzaghi F., Bontempi B. et al. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sci 1998;62:1601-6.</p><p>Wilens T.E., Biederman J., Spencer T.J. et al. A Pilot Controlled Clinical Trial of ABT418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder. Am J Psychiatry 1999;156:1931-7.</p><p>Kawamata J., Suzuki S., Shimohama S. Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models. Ther Advanc Chron Dis 2011;2:197-208.</p><p>Heron S.E., Scheffer I.E., Berkovic S.F. et al. Channelopathies in idiopathic epilepsy. Neurotherapeutics 2007;4:295-304.</p><p>Meisler M.H., Kearney J., Ottman R. et al. Identification of epilepsy genes in human and mouse. Ann Rev Genet 2001;35:567-88.</p><p>Broide R.S., Salas R., Daoyun Ji et al. Increased Sensitivity to Nicotine-Induced Seizures in Mice Expressing the L250T7 Nicotinic Acetylcholine Receptor Mutation. Mol Pharmacol 2002;61:695-701.</p><p>Yokota T., Kagamihara Y., Hayashi H. et al. Nicotine-sensitive paresis. Neurology 1992;42:382.</p><p>Brodtkorb E., Picard F. Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Behav 2006;9:515-20.</p><p>Eeg-Olofsson O. The genetics of benign child benign childhood epilepsy with centrotemporal spikes. In: Berkovic S.F., Genton P., Picard F. (eds). Genetics of focal epilepsies: Clinical aspects and molecular biology. John Libbey & Company Ltd, 2000;35-41.</p><p>Leniger T., Kananura C., Hufnagel A. et al. A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia 2003;44:981-95.</p><p>Leonard S., Bertrand D. Neuronal nicotinic receptors: from structure to function. Nicotine Tob Res 2001;3:203-23.</p></div><br /><div><p>Статистика курения. russlav.ru _ stat/statis-tika_kyreniya.html</p><p>IARC. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.</p><p>WHO. http://www.who.int/mediacentre/news/releas- es/pr82/en. 2002</p><p>WHO. http://www.who.int/tobacco/health_priority/en /print.html. 2007.</p><p>Dworetzky B.A., Bromfield E.B., Townsend M.K. et al. A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: data from the Nurses' Health Study II. Epilepsia 2010;51:198-205.</p><p>Elliott J.O., Lu B., Moore J.L. et al. Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on the California Health Interview Survey, 2005. Epilepsy Behav 2008;13:307-15.</p><p>Elliott J.O., Moore J.L., Lu B. Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System. Epilepsy Behav 2008;12:434-44.</p><p>Kobau R., DiIorio C.A., Price P.H. et al. Prevalence of epilepsy and health status of adults with epilepsy in Georgia and Tennessee: Behavioral Risk Factor Surveillance System, 2002. Epilepsy Behav 2004;5:358-66.</p><p>Konda K., Ablah E., Konda K.S. et al. Health behaviors and conditions of persons with epilepsy: a bivariate analysis of 2006 BRFSS data. Epilepsy Behav 2009;16:120-7.</p><p>Зенков Л.Р. Клиническая эпилептология (руководство для врачей). 2-е изд. М.: МИА, 2010;408 с.</p><p>Usui N., Kotagal P., Matsumoto R. et al. Focal semiologic and electroencephalographic features in patients with juvenile myoclonic epilepsy. Epilepsia 2005;46:1668-76.</p><p>Panayiotopoulos C.P. A clinical guide to epileptic syndromes and their treatment. Springer, 2010;620 р</p><p>Reinsberger C., Dorn T., Kramer.G. Smoking reduces serum levels of lamotrigine. Seizure 2008;17:651-3.</p><p>Hong E.L., Gu H., Yang Y. et al. Association of Nicotine Addiction and 14. Nicotine's Actions With Separate Cingulate Cortex Functional Circuits. Arch Gen Psychiat 2009;66:431-41.</p><p>Albuquerque E.X., Pereira E.F.R., Alkondon M. et al. Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function. Physiol Rev 2009;89:73-120.</p><p>Court J.A., Piggott M.A., Lloyd S. et al. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 2000;98:79-87.</p><p>Orth M., Amann B., Robertson M.M. et al. Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. Brain 2005;128:1292-300.</p><p>Silver A.A., Shytle R.D., Philipp M.K. et al. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. J Clin Psychiatry 2001;62:707-14.</p><p>White H.K., Levin E.D. Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. Psychopharmacology 2004;171:465-71.</p><p>Berkovic S.F., Scheffer I.E. Genetic of partial epilepsies: new frontiers. In: Genetics of focal epilepsies: Berkovic S.F., Genton P., Picard F. (eds.) Clinical aspects and molecular biology. John Libbey & Company Ltd., 2000;7-14.</p><p>Chen Y., Wu L., Fang Y. et al. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. Epilepsy Res 2009;83:152-6.</p><p>Fedi M., Berkovic S.F., Scheffer I.E. et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy. Neurology 2008;71:795-8</p><p>Hoda J.C., Gu W., Marc F. et al. Human Nocturnal Frontal Lobe Epilepsy: Pharmocogenomic Profiles of Pathogenic Nicotinic Acetylcholine Receptor β-Subunit Mutations outside the Ion Channel Pore. Mol Pharmacol 2008;74:379-91.</p><p>Kedmi M., Orr-Urtreger A. Expression changes in mouse brains following nicotine-induced seizures: the modulation of transcription factor networks. Physiol Genomics 2007;30:242-52.</p><p>Mulley J.C., Scheffer I.E., Petrou S. et al. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003;16:171-6.</p><p>Phillips H.A., Favre I., Kirkpatrick M. et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001;68:225-31.</p><p>Steinlein O.K. Human disorders caused by the disruption of the regulation of excitatory neurotransmission. Results Probl Cell Differ 2008;44:223-42.</p><p>Willoughby J.O., Pope K.J., Eaton V. Nicotine as an antiepileptic agent in ADNFLE: an N-of-one study. Epilepsia 2003;44:1238-40.</p><p>Lloyd G.K., Menzaghi F., Bontempi B. et al. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sci 1998;62:1601-6.</p><p>Wilens T.E., Biederman J., Spencer T.J. et al. A Pilot Controlled Clinical Trial of ABT418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder. Am J Psychiatry 1999;156:1931-7.</p><p>Kawamata J., Suzuki S., Shimohama S. Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models. Ther Advanc Chron Dis 2011;2:197-208.</p><p>Heron S.E., Scheffer I.E., Berkovic S.F. et al. Channelopathies in idiopathic epilepsy. Neurotherapeutics 2007;4:295-304.</p><p>Meisler M.H., Kearney J., Ottman R. et al. Identification of epilepsy genes in human and mouse. Ann Rev Genet 2001;35:567-88.</p><p>Broide R.S., Salas R., Daoyun Ji et al. Increased Sensitivity to Nicotine-Induced Seizures in Mice Expressing the L250T7 Nicotinic Acetylcholine Receptor Mutation. Mol Pharmacol 2002;61:695-701.</p><p>Yokota T., Kagamihara Y., Hayashi H. et al. Nicotine-sensitive paresis. Neurology 1992;42:382.</p><p>Brodtkorb E., Picard F. Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Behav 2006;9:515-20.</p><p>Eeg-Olofsson O. The genetics of benign child benign childhood epilepsy with centrotemporal spikes. In: Berkovic S.F., Genton P., Picard F. (eds). Genetics of focal epilepsies: Clinical aspects and molecular biology. John Libbey & Company Ltd, 2000;35-41.</p><p>Leniger T., Kananura C., Hufnagel A. et al. A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia 2003;44:981-95.</p><p>Leonard S., Bertrand D. Neuronal nicotinic receptors: from structure to function. Nicotine Tob Res 2001;3:203-23.</p></div><br />
The authors declare that there are no conflicts of interest present.